Helping African Americans quit smoking with extended treatment
Improving smoking abstinence outcomes in the African American community through extended treatment
This study is looking to help African American smokers quit smoking more successfully by testing a longer treatment with a medication called varenicline, along with extra support, to see if it can help them stay smoke-free for good.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-11075800 on NIH RePORTER |
What this research studies
This research focuses on improving smoking cessation outcomes specifically for African American smokers, who face significant health disparities related to tobacco use. The study will evaluate the effectiveness of extended treatment with varenicline, a medication approved for helping people quit smoking, to see if it can enhance abstinence rates among light, moderate, and heavy smokers in this community. By assessing medication adherence and the impact of prolonged support, the research aims to identify effective strategies for promoting long-term quitting. Participants will receive support and resources tailored to their needs throughout the treatment process.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American adults who smoke cigarettes and are seeking help to quit.
Not a fit: Patients who do not smoke or are not part of the African American community may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved smoking cessation rates and reduced health disparities for African American smokers.
How similar studies have performed: While extended treatment has shown success in White smokers, this approach has not been previously tested in African American smokers, making it a novel investigation.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Cox, Lisa Sanderson — University of Kansas Medical Center
- Study coordinator: Cox, Lisa Sanderson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.